Antonio Maiorana

ORCID: 0000-0001-7122-6136 · 27 papers in corpus · active 2007-2026

Study types

  • article 18
  • other 4
  • review 4
  • letter 1

Condition tags

  • endometriosis 20
  • mesh:D004715 14
  • dysmenorrhea 9
  • adenomyosis 7
  • mesh:D017699 5
  • chronic_pelvic_pain 5
  • mesh:D004412 4
  • infertility 4
  • dyspareunia 4
  • mesh:D004414 2
review 2026
Frontiers in reproductive health ·doi:10.3389/frph.2026.1760832

Adenomyosis is an estrogen-dependent uterine disorder increasingly recognized as a major cause of infertility and adverse obstetric outcomes, yet optimal medical preparation before embryo transfer (ET) remains uncertain. Adenomyotic lesions…

other 2026
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70991

OBJECTIVE: To evaluate whether junctional zone (JZ) adenomyosis adversely affects assisted reproductive technologies (ART) outcomes in infertile women undergoing their first single embryo transfer (SET) using donor oocytes. METHODS: This r…

review 2026
Human reproduction open ·doi:10.1093/hropen/hoaf064

STUDY QUESTION: Are endometriotic lesions affecting bilateral organs or anatomical structures distributed symmetrically on both sides of the body? SUMMARY ANSWER: The left-sided preponderance of pelvic endometriotic lesions, and the right-…

article 2026
·doi:10.6084/m9.figshare.32049406

To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids. This case…

article 2026
·doi:10.6084/m9.figshare.32049406.v1

To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids. This case…

other 2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2026.2659439

OBJECTIVE: To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids…

other 2025
BMC complementary medicine and therapies ·doi:10.1186/s12906-025-04913-y

BACKGROUND: Endometriosis (E) is an oestrogen-dependent, multifactorial, inflammatory disease causing pelvic pain and infertility. Several concerns have been raised about the role of food contaminants, in particular Bis(2-ethylhexyl) phthal…

article 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07271-7

PURPOSE: To evaluate the efficacy and long-term safety (up to 108 months) of treatment with Dienogest in patients with endometriosis. METHODS: Patients with chronic pelvic pain endometriosis-related were enrolled in this observational study…

other 2023
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2023.03.017

The evaluation of endometriosis in an adolescent girl is a challenging topic. The initial stage of the disease and the limited diagnostic instrument appropriate for the youth age and for its typical features can reduce the ability of the gy…

article 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-06942-9

PURPOSE: The aims of this observational study were: to assess the relationship between psychological variables, pain, Duration Untreated Endometriosis (DUE) in a sample of women with Endometriosis; and to assess the effect of dienogest 2 mg…

article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2128644

Purpose The aim of the study was to assess the length of diagnostic delay of symptomatic endometriosis in Italy and analyse the presence of correlations between the socio-demographic status of patients and the clinical characteristics/type …

article 2021
·doi:10.5114/hm.2021.103295

Purpose Endometriosis is a painful pathology impairing women’s daily life. Several studies have shown that patients report low mental and physical quality of life, but no general evaluation of their self-esteem has been found. Studies conce…

article 2020
·doi:10.1177/2284026520966504

The presence of catamenial epilepsy in patients diagnosed with endometriosis is the symptom that would direct towards a suspected cerebral endometriotic localization. However, data research of medical literature supporting this diagnosis sh…

review 2019
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2018.1549213

The incidence of endometriosis in middle-aged women is not minimal compared to that in the reproductive age group. The treatment of affected women after childbearing age to the natural transition toward menopause has received considerably p…

article 2019
Human reproduction open ·doi:10.1093/hropen/hoz009

A network of endometriosis experts from 16 Italian academic departments and teaching hospitals distributed all over the country made a critical appraisal of the available evidence and definition of 10 suggestions regarding measures to be de…

article 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4442-5
article 2017
·doi:10.5301/jeppd.5000292

Endometriosis causes a decrease in fertility in affected patients. The different forms of the disease, peritoneal, ovarian, deep infiltrating and adenomyosis, are often present in varying degrees in the same patient, either together or indi…

review 2016
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.12.017

A panel of experts in the field of endometriosis expressed their opinions on management options in a 28-year-old patient, attempting pregnancy for 1 year, with severe cyclic pelvic pain and with clinical examination and imaging techniques s…

article 2016
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0000000000000779
article 2015
Human Reproduction ·doi:10.1093/humrep/dev313

STUDY QUESTION: Is the combined excisional/ablative technique for the treatment of ovarian endometriomas better than the traditional stripping technique in terms of recurrence rate? SUMMARY ANSWER: There is no evidence that the combined exc…

article 2015
·doi:10.5301/je.5000232

Background The aim of this study was to assess the efficacy of dienogest treatment in improving quality of life in women with endometriosis. Methods This was a prospective observational multicenter study at the universities of Siena, Milano…

article 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.01.021
letter 2015
Journal of gynecologic oncology ·doi:10.3802/jgo.2015.26.2.168

A new generation of three dimensional (3D) imaging software for the anatomical rendering of the human body, and related surgical pathologies, is postulated. Its practical application is underlined.

article 2012
Minerva ginecologica

AIM: Our goals were to assess the psychometrical characteristics of EHP-30, to test its higher degree of appropriateness compared to the generic Quality of Life-assessment tools for Italian women suffering from endometriosis, and to determi…

article 2011
·doi:10.5301/je.2011.8537

Purpose Endometriosis remains a challenging condition for clinicians, research scientists, and patients alike. Routine clinical examination is insufficient to diagnose and evaluate the extent of pelvic endometriosis which can be assessed by…